HTDI 2022

Event Details

  • Start Date 12/15/2022
  • Start Time 08:30
  • End Time 00:00
Topics Speakers Time Venue
A-V ACCESS FOR HAEMODYALISIS 08.15-09.24 Session 16
Clinical evidence on management of clotted haemodialysis access: VITAE registry 8.16
Vascular access for haemodialysis 8.22
Optimizing functional patency in AVG: what treatment and when 8.28
External support device for AVF: the next standard of care? An all clinical data update 8.34
ESVS clinical practice guidelines 8.40
AFV creation: comparing surgical and percutaneous outcomes 8.46
Will endoAV fistulas ever become the gold standard? Surgery is still the gold standard 8.52
Is there any current role for DCB and DES? 8.58
How to avoid and how to manage haemodialysis access failure: tips and tricks 9.04
How does EndoAVF fit into patient's life plan: not only creating an AV fistula but also making a difference 9.10
Round table/Discussion 9.16-9.24
MISCELLANEA | PERIPHERAL DISEASE 09.25-10.24 Session 17
15 years preserving hypogastric arteries - Results from pELVIS registry 9.26
What is a good vein? Heparin Bonded Grafts vs Vein for BTK by-pass in CLTI: when to use what? 9.32
Visceral artery aneurysms – Experience with more than 230 cases 9.38
Superior mesenteric artery syndrome and treatment 9.44
How do I find my way to the true lumen and when do I stent visceral branches? 9.50
Drug eluting stent: superior primary patency in the treatment of PAD 9.56
Modern approach for long SFA occlusion 10.02
Distal bypass surgery: how to achieve life long success? How do I do it 10.08
Round table/Discussion 10.14-10.24
MISCELLANEA | AORTIC DISEASE 10.25-11.44 Session 18
Long term results of Ilac branch endografts 10.26
Lessons learned in the treatment of uncommon visceral arteries 10.32
Post coarctation aneurysms: results of an international registry 10.38
Initial experience in endovascular treatment of aortic arch aneurysm 10.44
Curvature remodelling after TEVAR 10.50
Outcomes of upper vs lower extremity access for F/BEVAR 10.56
Custom made solution with inner branch technology: technical issues and results of Celer Study 11.02
ESAR can improve EVAR outcomes in hostile sealing zones: insights from ANCHOR registry 11.08
Reconsidering aortic sealing in a dynamic environment 11.14
Midaortic syndrome and renovascular disease in pediatric population: decision making & surgical strategy 11.20
Update on different types of inner branch endografts 11.26
Off the shelf modified TEVAR solution: single center experience 11.32
Round table/Discussion 11.38-11.49
KEYNOTE LECTURE VIII 11.50-12.04
INFECTIONS/ENDOLEAKS 12.05-13.14 Session 19
Bovine pericardial tube for aortic replacement in surrounding infectious bed 12.06
Xenopericardial grafts for native and graft-related aortic infections 12.12
Graft infection European guidelines 12.18
Surgical treatment of native and prosthetic aortic infection with xenopericardial tube-grafts from the ascending aorta beyond the bifurcation 12.24
Treatment of refractory Type II EL: from embolization to conversion 12.30
Technical tips to perform safe large percutaneous femoral access for complex AAA EVAR in obese or scarred groins; results from trans-atlantic collaboration 12.36
The treatment of aortic prosthetic infection with homograft 12.42
Transcaval embolisation for endoleak Type II 12.48
Management of aortic graft infections – results from a large nationwide study 12.54
Mycotic aortic aneurysms: open vs endovascular or can we have the best of both worlds? 13.00
Round table/Discussion 13.06-13.14